Mirum Pharma to Showcase Livmarli & Volixibat Data at AASLD
14 Nov 2024 //
BUSINESSWIRE
Mirum’s Volixibat Achieves Positive Interim Analyses In VANTAGE PBC
17 Jun 2024 //
BUSINESSWIRE
Mirum To Host Call On Volixibat VANTAGE VISTAS Interim Analysis
16 Jun 2024 //
BUSINESSWIRE
Mirum Pharma to Showcase Analyses From Its Rare Liver Disease Programs at ILC
16 Jun 2021 //
BUSINESSWIRE
Mirum spells out plans to turn Shire discards into orphan liver drug successes
24 Jun 2019 //
ENDPTS
Immunology keeps Shire figures solid as Takeda takeover nears
31 Jul 2018 //
PM LIVE